Antifibrinolytic use and blood transfusions in pediatric scoliosis surgeries performed at US children's hospitals

Journal of Spinal Disorders and Techniques

Volumn 28, Issue 8, 2015, Pages E460-E466

  McLeod, Lisa M ^a   French, Benjamin ^b   Flynn, John M ^b,c   Dormans, John P ^b,c   Keren, Ron ^b,c  

^a CHILDREN S HOSPITAL COLORADO   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Adolescent idiopathic scoliosis; Antifibrinolytic therapy; Blood conservation; Blood transfusion; Neuromuscular scoliosis; Practice variation; Spinal fusion

Indexed keywords

AMINOCAPROIC ACID; APROTININ; TRANEXAMIC ACID; ANTIFIBRINOLYTIC AGENT;

ADOLESCENT; ADOLESCENT IDIOPATHIC SCOLIOSIS; ADULT; ANTIFIBRINOLYTIC THERAPY; ARTICLE; CHILD; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DRUG EFFICACY; DRUG THERAPY; ERYTHROCYTE TRANSFUSION; FEMALE; HEALTH CARE COST; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION SYSTEM; NEUROMUSCULAR DISEASE; NEUROMUSCULAR SCOLIOSIS; NEWBORN; OPERATIVE BLOOD LOSS; PEDIATRIC HOSPITAL; PEDIATRIC SURGERY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCOLIOSIS; SPINE FUSION; SURGICAL PATIENT; TREATMENT OUTCOME; UNITED STATES; BLOOD TRANSFUSION; CONFIDENCE INTERVAL; HOSPITAL; ODDS RATIO; PRESCHOOL CHILD;

ADOLESCENT; ANTIFIBRINOLYTIC AGENTS; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; CONFIDENCE INTERVALS; FEMALE; HOSPITALS; HUMANS; INFANT; INFANT, NEWBORN; MALE; ODDS RATIO; SCOLIOSIS; UNITED STATES;

EID: 84942119637     PISSN: 15360652     EISSN: 15392465     Source Type: Journal    
DOI: 10.1097/BSD.0b013e3182a22a54     Document Type: Article

References (34)

1. Kannan S, Meert KL, Mooney JF, et al. Bleeding and coagulation changes during spinal fusion surgery: a comparison of neuromuscular and idiopathic scoliosis patients. Pediatr Crit Care Med. 2002;3:364-369.
2. Shapiro F, Sethna N. Blood loss in pediatric spine surgery. Eur Spine J. 2004;13(suppl 1):S6-S17.
3. Meert KL, Kannan S, Mooney JF. Predictors of red cell transfusion in children and adolescents undergoing spinal fusion surgery. Spine (Phila Pa 1976). 2002;27:2137-2142.
4. Neilipovitz DT, Murto K, Hall L, et al. A randomized trial of tranexamic acid to reduce blood transfusion for scoliosis surgery. Anesth Analg. 2001;93:82-87.
5. Barcelona SL, Thompson AA, Cote CJ. Intraoperative pediatric blood transfusion therapy: a review of common issues. Part II: transfusion therapy, special considerations, and reduction of allogenic blood transfusions. Paediatr Anaesth. 2005;15: 814-830.
6. Lalueza MP, Colomina MJ, Bago J, et al. Analysis of nutritional parameters in idiopathic scoliosis patients after major spinal surgery. Eur J Clin Nutr. 2005;59:720-722.
7. Hill GE, Frawley WH, Griffith KE, et al. Allogeneic blood transfusion increases the risk of postoperative bacterial infection: a meta-analysis. J Trauma. 2003;54:908-914.
8. Blanchette CM, Wang PF, Joshi AV, et al. Cost and utilization of blood transfusion associated with spinal surgeries in the United States. Eur Spine J. 2007;16:353-363.
9. Schuster JM, Rechtine G, Norvell DC, et al. The influence of perioperative risk factors and therapeutic interventions on infection rates after spine surgery: a systematic review. Spine (Phila Pa 1976). 2010;35:S125-S137.
10. Thompson GH, Florentino-Pineda I, Poe-Kochert C, et al. Role of Amicar in surgery for neuromuscular scoliosis. Spine (Phila Pa 1976). 2008;33:2623-2629.
11. Kasimian S, Skaggs DL, Sankar WN, et al. Aprotinin in pediatric neuromuscular scoliosis surgery. Eur Spine J. 2008;17:1671-1675.
12. Sethna NF, Zurakowski D, Brustowicz RM, et al. Tranexamic acid reduces intraoperative blood loss in pediatric patients undergoing scoliosis surgery. Anesthesiology. 2005;102:727-732.
13. Florentino-Pineda I, Blakemore LC, Thompson GH, et al. The effect of epsilon-aminocaproic acid on perioperative blood loss in patients with idiopathic scoliosis undergoing posterior spinal fusion: a preliminary prospective study. Spine (Phila Pa 1976). 2001; 26:1147-1151.
14. Cole JW, Murray DJ, Snider RJ, et al. Aprotinin reduces blood loss during spinal surgery in children. Spine (Phila Pa 1976). 2003;28: 2482-2485.
15. Florentino-Pineda I, Thompson GH, Poe-Kochert C, et al. The effect of amicar on perioperative blood loss in idiopathic scoliosis: the results of a prospective, randomized double-blind study. Spine (Phila Pa 1976). 2004;29:233-238.
16. Tzortzopoulou A, Cepeda MS, Schumann R, et al. Antifibrinolytic agents for reducing blood loss in scoliosis surgery in children. Cochrane Database Syst Rev. 2008;CD006883.
17. Strom BL, Kimmel SE, Hennessy S. Pharmacoepidemiology. 5th ed. Chichester, West Sussex, UK: Wiley-Blackwell; 2012.
18. McLeod LM, Keren R, Gerber J, et al. Perioperative antibiotic use for spinal surgery procedures in US Children's Hospitals. Spine (Phila Pa 1976). 2013;38:609-616.
19. Simon TD, Berry J, Feudtner C, et al. Children with complex chronic conditions in inpatient hospital settings in the United States. Pediatrics. 2010;126:647-655.
20. Graubard BI, Korn EL. Predictive margins with survey data. Biometrics. 1999;55:652-659.
21. Henry DA, Carless PA, Moxey AJ, et al. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2011;CD001886.
22. Berenholtz SM, Pham JC, Garrett-Mayer E, et al. Effect of epsilon aminocaproic acid on red-cell transfusion requirements in major spinal surgery. Spine (Phila Pa 1976). 2009;34:2096-2103.
23. Moore FA, Moore EE, Sauaia A. Blood transfusion. An independent risk factor for postinjury multiple organ failure. Arch Surg. 1997;132:620-624; discussion 624-625.
24. Vamvakas EC, Blajchman MA. Deleterious clinical effects of transfusion-associated immunomodulation: fact or fiction? Blood. 2001;97:1180-1195.
25. Mooney JF. Validity of estimates of intraoperative blood loss in pediatric spinal deformity surgery. Spine Deformity. 2013;1: 21-24.
26. Hassan NE, Winters J, Winterhalter K, et al. Effects of blood conservation on the incidence of anemia and transfusions in pediatric parapneumonic effusion: a hospitalist perspective. J Hosp Med. 2010;5:410-413.
27. Verma RR, Williamson JB, Dashti H, et al. Homologous blood transfusion is not required in surgery for adolescent idiopathic scoliosis. J Bone Joint Surg Br. 2006;88:1187-1191.
28. Sherman CH, Macivor DC. Blood utilization: fostering an effective hospital transfusion culture. J Clin Anesth. 2012;24:155-163.
29. Farrokhi MR, Kazemi AP, Eftekharian HR, et al. Efficacy of prophylactic low dose of tranexamic acid in spinal fixation surgery: a randomized clinical trial. J Neurosurg Anesthesiol. 2011;23: 290-296.
30. Grant JA, Howard J, Luntley J, et al. Perioperative blood transfusion requirements in pediatric scoliosis surgery: the efficacy of tranexamic acid. J Pediatr Orthop. 2009;29:300-304.
31. Elwatidy S, Jamjoom Z, Elgamal E, et al. Efficacy and safety of prophylactic large dose of tranexamic acid in spine surgery: a prospective, randomized, double-blind, placebo-controlled study. Spine (Phila Pa 1976). 2008;33:2577-2580.
32. Jain A, Njoku DB, Sponseller PD. Does patient diagnosis predict blood loss during posterior spinal fusion in children? Spine (Phila Pa 1976). 2012;37:1683-1687.
33. Sanders JO, Haynes R, Lighter D, et al. Variation in care among spinal deformity surgeons: results of a survey of the Shriners hospitals for children. Spine (Phila Pa 1976). 2007;32:1444-1449.
34. Vitale MG, Gomez JA, Matsumoto H, et al. Variability of expert opinion in treatment of early-onset scoliosis. Clin Orthop Relat Res. 2011;469:1317-1322.